The invention relates to compounds of formula (I) ##STR00001## processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.

 
Web www.patentalert.com

< Fluorophosphonocinnamic compounds, synthesis and uses for treating disorders caused by oxidative stress

> Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas

> Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
~ 00511